Drug Discovery & Pharmaceuticals

RSS

Experimental compound reduces destructive inflammation to improve stroke outcome

An experimental compound appears to improve stroke outcome by reducing the destructive inflammation that can continue months after a stroke, scientists report.

20 Apr 2018

Tradeshow Talks with FarmaTrust

The Farmatrust was formed in 2016 with the vision that we will have consumer apps to figure out the authenticity of the drug at a packet level.

19 Apr 2018

Genetic make-up impacts long-term effectiveness of phobia treatment

Researchers have discovered that variations in the efficacy of psychological treatment for phobias are associated with the serotonin transporter gene.

19 Apr 2018

Novel biomarker can distinguish between benign and malignant lung nodules

Researchers report a newly developed biomarker was 98% effective at distinguishing between benign and malignant lung nodules in a recent multicentre clinical trial.

18 Apr 2018

Researchers discover potential hurdle for personalized medicine

A recent study has shown that loss of the Erk oncogene can stimulate tumorigenesis in cells where Ras has been eliminated. The findings may have important consequences for the development of personalized medicines that target Ras.

17 Apr 2018

Artificial antimicrobial peptides may help fight against drug-resistant bacteria

During the past several years, many strains of bacteria have become resistant to existing antibiotics, and very few new drugs have been added to the antibiotic arsenal.

16 Apr 2018

Researchers use graphene to disrupt biofilms on dental implants

Researchers from Chalmers University of Technology, Sweden have demonstrated that a layer of graphene can form a protective film on the surface of implants that could prevent bacterial infection.

16 Apr 2018

Researchers use graphene to disrupt biofilms on dental implants

Researchers from Chalmers University of Technology, Sweden have demonstrated that a layer of graphene can form a protective film on the surface of implants that could prevent bacterial infection.

16 Apr 2018

SYGNIS AG extends manufacturing capability for Lightning-Link technology

SYGNIS AG, the Group which includes Expedeon Holdings, Expedeon, and C.B.S. Scientific Company, today announced it has extended the manufacturing capability for its Lightning-Link technology, currently marketed under the Expedeon brand, to support scalability and bulk production of antibodies.

16 Apr 2018

Researchers develop new tool to protect against HIV infection

Researchers at the University of Waterloo have developed a vaginal implant based on the theory of immune quiescence that could prevent women from contracting HIV.

16 Apr 2018

Researchers create biocompatible gels using caffeine as catalyst

Caffeine is well-known for its ability to help people stay alert, but a team of researchers at MIT and Brigham and Women's Hospital has now come up with a novel use for this chemical stimulant -- catalyzing the formation of polymer materials.

13 Apr 2018

Experimental molecular therapy to block matrix-forming protein may prevent heart failure

Scientists used an experimental targeted molecular therapy to block a matrix-forming protein in heart cells damaged by heart attack, reducing levels of scarred muscle tissue and saving mouse models from heart failure.

13 Apr 2018

Intranasal spray shows promise for peanut allergy suppression

A vaccine delivered in the form of an ultrafine nasal spray has been shown to protect against allergy symptoms peanut sensitive mice.

13 Apr 2018

Scientists from Cure First and SEngine Precision Medicine discover common link in 28% of all cancers

Seattle scientists from Cure First, a non-profit research organization, and SEngine Precision Medicine, a biotech developing targeted, more effective, and less toxic cancer therapeutics, co-authored one of 27 high-profile papers published today by Cell Press.

13 Apr 2018

KU Cancer Center to present evidence supporting anti-cancer drug at AACR 2018

The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association for Cancer Research 2018 Annual Meeting in Chicago. Ciclopirox Prodrug was discovered by researchers at The University of Kansas Cancer Center and KU's Institute for Advancing Medical Innovation.

12 Apr 2018

Researchers get one step closer to creating peptide vaccine against atherosclerosis

In the disease atherosclerosis, cholesterol-containing plaques form in vessel walls, causing arteries to narrow and greatly increasing the risk of heart attack and stroke.

12 Apr 2018

Nearly one billion people to be vaccinated against yellow fever in African countries by 2026

Nearly one billion people will be vaccinated against yellow fever in 27 high-risk African countries by 2026 with support from WHO, Gavi – the Vaccine Alliance, UNICEF and more than 50 health partners.

12 Apr 2018

Scientists developing new vaccines against heroin and prescription opioids

Heroin and prescription opioid abuse and fatal overdoses are a public health emergency in the United States. Vaccines offer a potential new strategy to treat opioid abuse and prevent fatal opioid overdoses.

12 Apr 2018

Experimental peptide drug shows promise against acute myeloid leukemia

In a study published online today in Science Translational Medicine, Albert Einstein College of Medicine researchers report that an experimental peptide drug shows promise against the often-lethal cancer acute myeloid leukemia and describe how the drug works at the molecular level.

11 Apr 2018

New class of drug holds potential to help patients with treatment-resistant cancers

Researchers have discovered a new class of drug that has the potential to help cancer patients who no longer respond to existing therapies.

10 Apr 2018

Drug Discovery & Pharmaceuticals

Experimental compound reduces destructive inflammation to improve stroke outcome

Tradeshow Talks with FarmaTrust

Genetic make-up impacts long-term effectiveness of phobia treatment

Novel biomarker can distinguish between benign and malignant lung nodules

Researchers discover potential hurdle for personalized medicine

Artificial antimicrobial peptides may help fight against drug-resistant bacteria

Researchers use graphene to disrupt biofilms on dental implants

Researchers use graphene to disrupt biofilms on dental implants

SYGNIS AG extends manufacturing capability for Lightning-Link technology

Researchers develop new tool to protect against HIV infection

Researchers create biocompatible gels using caffeine as catalyst

Experimental molecular therapy to block matrix-forming protein may prevent heart failure

Intranasal spray shows promise for peanut allergy suppression

Scientists from Cure First and SEngine Precision Medicine discover common link in 28% of all cancers

KU Cancer Center to present evidence supporting anti-cancer drug at AACR 2018

Researchers get one step closer to creating peptide vaccine against atherosclerosis

Nearly one billion people to be vaccinated against yellow fever in African countries by 2026

Scientists developing new vaccines against heroin and prescription opioids

Experimental peptide drug shows promise against acute myeloid leukemia

New class of drug holds potential to help patients with treatment-resistant cancers

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest Life Science News